PATENT CLAIM ANALYSIS

Application Number: 16241184
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["424", "495000"]

Abstract:
The present invention relates to a pharmaceutical composition comprising Levetiracetam, Brivaracetam or Seletracetam as active ingredient, the invention relates specifically to a prolonged release formulation.

Claim (Index 1):
A pharmaceutical composition comprising a granulate containing an inert core which is coated by a first layer comprising an active ingredient and at least one excipient, this first layer being coated by a controlled release layer, and the active ingredient being an 2-oxo-1-pyrrolidine derivative of formula (I), wherein, R 1  is H, C 1-10  alkyl or C 2-6  alkenyl; R 2  is C 1-10  alkyl or C 2-6  alkenyl; X is \u2014CONR 4 R 5 , \u2014COOH, \u2014COOR 3  or \u2014CN; R 3  is C 1-10  alkyl; R 4  is hydrogen or C 1-10  alkyl; R 5  is hydrogen or C 1-10  alkyl.

Metadata:
- Claim Count in Document: 21.0
- Percentile: 99.0
- Lexical Diversity: 1.21739
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13129114', '13128950', '13148175', '12993704', '12678406']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7352074867144627
- 35 USC 102 Novelty (BERT): 0.5901323994353669
- Combined Prediction Score: 0.7206999779865532
- Mean Citation Score: 329.5836920000001
- Max Citation Score: 543.97235
- Similarity Product: 424.9616356024176

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test